Press release
Global Retinopathy Of Prematurity Market Research Report - Pipeline Review, H2 2017
About Retinopathy Of Prematurity Market
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Retinopathy Of Prematurity-Pipeline Review, H2 2017, provides an overview of the Retinopathy Of Prematurity (Ophthalmology) pipeline landscape.
Retinopathy of prematurity (ROP) is a disease that affects immature vasculature in the eyes of premature babies. This disorder which usually develops in both eyes is one of the most common causes of visual loss in childhood and can lead to lifelong vision impairment and blindness Risk factors for the development of ROP include prematurity, extremely low-birth-weight, and multiple births.
Request For Sample Report @ https://www.marketresearchreports.biz/sample/sample/1339588
Report Highlights
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Retinopathy Of Prematurity-Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Retinopathy Of Prematurity (Ophthalmology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Retinopathy Of Prematurity (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Retinopathy Of Prematurity and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Preclinical and Discovery stages are 1, 2, 4 and 2 respectively.
Retinopathy Of Prematurity (Ophthalmology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
View Sample PDF @ https://www.marketresearchreports.biz/reports/1339588/retinopathy-of-prematurity-pipeline-review-h2-2017-market-research-reports.pdf
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Retinopathy Of Prematurity (Ophthalmology).
- The pipeline guide reviews pipeline therapeutics for Retinopathy Of Prematurity (Ophthalmology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Retinopathy Of Prematurity (Ophthalmology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Retinopathy Of Prematurity (Ophthalmology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Retinopathy Of Prematurity (Ophthalmology)
Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Retinopathy Of Prematurity (Ophthalmology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Retinopathy Of Prematurity (Ophthalmology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Have Any Query? Ask Our Expert @ https://www.marketresearchreports.biz/sample/enquiry/1339588
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Retinopathy Of Prematurity-Overview
Retinopathy Of Prematurity-Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Retinopathy Of Prematurity-Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Retinopathy Of Prematurity-Companies Involved in Therapeutics Development
Biomar Microbial Technologies
D. Western Therapeutics Institute Inc
F. Hoffmann-La Roche Ltd
Insmed Inc
Recordati SpA
Retinopathy Of Prematurity-Drug Profiles
Drug for Retinopathy of Prematurity-Drug Profile
Product Description
Mechanism Of Action
R&D Progress
IB-09A0133-Drug Profile
Product Description
Mechanism Of Action
R&D Progress
mecasermin rinfabate-Drug Profile
Product Description
Mechanism Of Action
R&D Progress
propranolol-Drug Profile
Product Description
Mechanism Of Action
R&D Progress
R-200-Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ranibizumab-Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Recombinant Protein for Oncology, Diabetic Retinopathy and Retinopathy Of Prematurity-Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule for Retinopathy of Prematurity-Drug Profile
Product Description
Mechanism Of Action
R&D Progress
vitamin A palmitate-Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Retinopathy Of Prematurity-Dormant Projects
Retinopathy Of Prematurity-Product Development Milestones
Featured News & Press Releases
Jun 30, 2016: Shire Announces Top-Line Results for Phase 2 Trial of SHP607 in Extremely Premature Infants
Jan 21, 2009: Insmed And Premacure Announce European Orphan Designation For IPLEX In Retinopathy Of Prematurity In Infants
Appendix
Methodology
Coverage
Secondary Research
Primary Research
About us
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Contact
Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
USA: Canada Toll Free: 866-997-4948
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Retinopathy Of Prematurity Market Research Report - Pipeline Review, H2 2017 here
News-ID: 761964 • Views: …
More Releases from MarketResearchReports.biz
Hydro-flyers Market: Moving Towards a Brighter Future
A hydro-flyer is an adventure sporting device which uses the propulsion of water jet technology to create continuous flight movement, where the lift and movement are controlled by the flyer. Hydro-flyers sporting devices make use of the flow of water power to drive the flyer to reach soaring heights. The rise in water sporting facilities is one of the major factors that promote the growth and demand for hydro-flyers in…
Outdoor Floodlights: Technology and Market Dynamics
Outdoor floodlights is a reliable, highly efficient, and economical solution for a wide range of outdoor applications. These lights are resistant to temperature fluctuations and they remain stable even in extreme climatic conditions. Unlike the traditional lights, floodlights remain stable and functional even in harsh climatic conditions. This makes them ideal for use in any climate and any outdoor application. Outdoor floodlights save a significant amount of energy and consume…
Snow Helmets Market Future Prospects and Regional Outlook
Riders are riding faster and getting bolder day by day. Hence, safety equipment need to be updated as per the requirement and changing time. Earlier, helmets were primarily used by extreme skiers and racers. They were used only on slopes. However, later, the use of helmets was made compulsory. Earlier, bulky black helmets were used by riders, which are outdated at present. Currently, new stylish helmets that can match with…
Predictions for 2019: Global Sparkling Water Dispensers Industry Is Set to Boom
Sparkling water dispensers are equipment used for dispensing carbonated water. These dispensers mix the still, filtered water with carbon dioxide before dispensing. Sparkling water dispensers are mostly used in households and commercial establishments such as amusement parks, hotels, restaurants, and sports arenas. A sparkling water dispenser has separate outlets for hot water and cold water. The hot water outlet does not require a separate filtration process. However, cold water is…
More Releases for Retinopathy
Global Diabetic Retinopathy (DR) Analysis Software Market Size by Application, T …
USA, New Jersey- According to Market Research Intellect, the global Diabetic Retinopathy (DR) Analysis Software market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The market for diabetic retinopathy (DR) analysis software is expanding steadily as a result of the rising incidence of diabetes and the…
Diabetic Retinopathy Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Diffuse Large B-Cell Lymphoma Pipeline Insight 2024" report provides comprehensive insights about 80+ Diffuse Large B Cell Lymphoma companies and 80+ Diffuse Large B Cell Lymphoma pipeline drugs in Diffuse Large B-Cell Lymphoma pipeline landscape. It covers the Diffuse Large B Cell Lymphoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It…
Diabetic Retinopathy Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Diabetic Retinopathy Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in the Diabetic Retinopathy pipeline landscape. It covers the Diabetic Retinopathy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diabetic Retinopathy pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the…
Diabetic Retinopathy Pipeline Insights Report 2023 (Updated)
(Albany, United States) As per DelveInsight's assessment, globally, the Diabetic Retinopathy Pipeline constitutes 50+ key companies continuously working towards developing 55+ Diabetic Retinopathy Pipeline treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analysis DelveInsight.
In the Diabetic Retinopathy Pipeline Report, a detailed description of the drug is given which includes the mechanism of action of the drug, clinical studies, Diabetic Retinopathy NDA approvals…
Diabetic Retinopathy - Drug Pipeline Landscape, 2022
New York, Global Diabetic Retinopathy Drug Pipeline Landscape report from Global Insight Services is the single authoritative source of intelligence on Diabetic Retinopathy Drug Pipeline Landscape. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market…
Europe Diabetic Retinopathy Industry Analysis 2023
Overview
Diabetic retinopathy (DR) is a watch ailment related to diabetic sufferers. The disorder takes place even as there may be dangerous to the retina due to diabetes. Without nicely-timed remedy, the disease also can reason bleeding inside the eyes, cloudy imaginative and prescient, and might even ruin the retina. DR is among the commonplace cause of loss of vision inside the diabetic population, sooner or later leading to blindness. From…
